Predictors for successful mobilization of peripheral blood progenitor cells with ESHAP + G-CSF in patients with pretreated non-hodgkin's lymphoma

Journal of the Chinese Medical Association

Volumn 71, Issue 6, 2008, Pages 279-285

  Liu, Jin Hwang ^a   Chen, Chih Cheng ^a,b   Bai, Li Yen ^a,c   Chao, Shu Chauo ^a   Chang, Mu Shin ^a   Lin, Jeong Shi ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Autologous transplantation; CD34; Leukapheresis; Non Hodgkin's lymphoma; Peripheral blood progenitor cell; Stem cell mobilization

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BRAIN LYMPHOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD STEM CELL; PREDICTION; STEM CELL MOBILIZATION;

EID: 48049098993     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(08)70123-0     Document Type: Article

References (24)

1. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, Anaissie E, Walker R, et al. Treatment of multiple myeloma. Blood 2004;103:20-32.
2. Schmitz N, Buske C, Gisselbrecht C. Autologous stem cell transplantation in lymphoma. Semin Hematol 2007;44:234-45.
3. Majhail NS, Weisdorf DJ, Defor TE, Miller JS, McGlave PB, Slungaard A, Arora M, et al. Long-term results of autologous Stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma. Biol Blood Marrow Transplant 2006; 12:1065-72.
4. Gratwohl A, Passweg J, Baldomero H, Urbano-Ispizua A. European Group for Blood and Marrow Transplantation. Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 2001;27:899-916.
5. Ergene U, Cagirgan S, Pehlivan M, Yilmaz M, Tombuloǧlu M. Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT). Transfus Apher Sci 2007;36:23-9.
6. + cell counts decrease hematological toxicity of autologous peripheral blood progenitor cell transplantation. Blood 1998;91:3148-55.
7. Haas R, Mohle R, Fruhauf S, Goldschmidt H, Witt B, Flentje M, Wannenmacher M, et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994;83: 3787-94.
8. + cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1997;19:303-10.
9. Assouline S, Sylvestre MP, Carriere P, Shustik C, Laneuville P. Comparison of peripheral blood progenitor cell yield from standard chemotherapy used in the treatment of lymphoid malignancies and high-dose cyclophosphamide: a retrospective review of 141 patients. Transfusion 2006;46:174-9.
10. Pavone V, Gaudio F, Guarini A, Perrone T, Zonno A, Curci P, Liso V. Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma. Bone Marrow Transplant 2002;29: 285-90.
11. Lee JL, Kim S, Kim SW, Kim EK, Kim SB, Kang YK, Lee J, et al. ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF. Bone Marrow Transplant 2005; 35:449-54.
12. 2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients. Br J Cancer 2000;82:278-82.
13. Ikeda K, Kozuka T, Harada M. Factors for PBPC collection efficiency and collection predictors. Transfus Apher Sci 2004; 31:245-59.
14. + cell count reliably predicts autograft yield. Bone Marrow Transplant 1998; 22:125-30.
15. Ketterer N, Salles G, Moullet I, Dumontet C, ElJaafari-Corbin A, Tremisi P, Thieblemont C, et al. Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. Br J Haematol 1998;103: 235-42.
16. Moskowitz CH, Glassman JR, Wuest D, Maslak P, Reich L, Gucciardo A, Coady-Lyons N, et al. Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clin Cancer Res 1998;4:311-6.
17. Zimmerman TM, Michelson GC, Mick R, Grinblatt DL, Williams SF. Timing of platelet recovery is associated with adequacy of leukapheresis product yield after cyclophosphamide and G-CSF in patients with lymphoma. J Clin Apheresis 1999; 14:31-4.
18. Petit J, Boque C, Cancelas JA, Sarrà J, Muñoz J, Garcia J, Grañena A. Feasibility of ESHAP + G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients. Leukemia Lymphoma 1999;34:119-27.
19. + concentration in peripheral blood. J Clin Oncol 1996;4:970-3.
20. Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M, Montserrat E, et al. International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol 1999; 17:423-9.
21. Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA, Romaguera J, et al. ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J Clin Oncol 1994;12: 1169-76.
22. Koumakis G, Vassilomanolakis M, Hatzichristou H, Barbounis V, Filis J, Papanastasiou K, Moraki M, et al. Predictive factors affecting mobilization and peripheral blood stem cell collection using single apheresis for rescuing patients after high-dose chemotherapy in various malignancies. Bone Marrow Transplant 1996;18:1065-72.
23. Drake M, Ranaghan L, Morris TC, Nolan L, Desai ZR, Irvine AE, Jordan A, et al. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system. Br J Haematol 1997;98:745-9.
24. Strehl J, Mey U, Glasmacher A, Djulbegovic B, Mayr C, Gorschlüter M, Ziske C, et al. High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis. Haematologica 2003;88:1304-15.